Dow Up 0.05% Nasdaq Down 0.18%

ACADIA Pharmaceuticals Inc. (ACAD)

-NasdaqGS
27.05 Down 0.48(1.74%) May 5, 4:00PM EDT
|Pre-Market : 29.33 Up 2.28 (8.43%) 7:01AM EDT
Prev Close:27.53
Open:27.89
Bid:27.76 x 100
Ask:29.27 x 400
1y Target Est:45.60
Beta:3.47619
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:26.56 - 27.95
52wk Range:16.64 - 51.99
Volume:3,573,388
Avg Vol (3m):3,232,750
Market Cap:3.05B
P/E (ttm):N/A
EPS (ttm):-1.63
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACADDown 1.74%3.05B
AZNDown 0.57%71.04B
PFEUp 0.51%207.86B
LLYUp 0.53%80.02B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):45,677.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.45
Quarterly EPS Est (Mar-16) :-0.42
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback